- Home
- EQH vs FBIOP Comparison
EQH vs FBIOP Comparison
Compare EQH & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQH
- FBIOP
- Stock Information
- Founded
- EQH 1859
- FBIOP N/A
- Country
- EQH United States
- FBIOP United States
- Employees
- EQH N/A
- FBIOP 101
- Industry
- EQH Specialty Insurers
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- EQH Finance
- FBIOP Health Care
- Exchange
- EQH Nasdaq
- FBIOP Nasdaq
- Market Cap
- EQH N/A
- FBIOP N/A
- IPO Year
- EQH N/A
- FBIOP N/A
- Fundamental
- Price
- EQH $52.83
- FBIOP $6.55
- Analyst Decision
- EQH Buy
- FBIOP
- Analyst Count
- EQH 12
- FBIOP 0
- Target Price
- EQH $60.25
- FBIOP N/A
- AVG Volume (30 Days)
- EQH 2.3M
- FBIOP N/A
- Earning Date
- EQH 04-29-2025
- FBIOP N/A
- Dividend Yield
- EQH 1.79%
- FBIOP N/A
- EPS Growth
- EQH 13.70
- FBIOP N/A
- EPS
- EQH 3.76
- FBIOP N/A
- Revenue
- EQH $15,105,000,000.00
- FBIOP N/A
- Revenue This Year
- EQH $21.47
- FBIOP N/A
- Revenue Next Year
- EQH $3.11
- FBIOP N/A
- P/E Ratio
- EQH $14.29
- FBIOP N/A
- Revenue Growth
- EQH 45.39
- FBIOP N/A
- 52 Week Low
- EQH $36.46
- FBIOP N/A
- 52 Week High
- EQH $56.00
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- EQH 59.56
- FBIOP 49.67
- Support Level
- EQH $49.63
- FBIOP $5.60
- Resistance Level
- EQH $55.07
- FBIOP $6.50
- Average True Range (ATR)
- EQH 1.11
- FBIOP 0.28
- MACD
- EQH 0.51
- FBIOP -0.04
- Stochastic Oscillator
- EQH 74.61
- FBIOP 47.75
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.